ImmuCell Corporation (ICCC) Operating cash flow 2016–2025
ImmuCell Corporation (ICCC) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$2.5MFY2025 · since FY2016: -$222,314 → $2.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $2.5M | +591.6% |
| FY2024 | $357,903 | +107.7% |
| FY2023 | -$4.7M | -202.8% |
| FY2022 | -$1.5M | -261.8% |
| FY2021 | $954,170 | -27.5% |
| FY2020 | $1.3M | +463.4% |
| FY2019 | $233,511 | +162.5% |
| FY2018 | -$373,404 | -131.8% |
| FY2017 | $1.2M | +628.9% |
| FY2016 | -$222,314 | — |
Source: SEC XBRL filings · For reference only · Not investment advice